Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $11.70 billion. The enterprise value is $11.42 billion.
| Market Cap | 11.70B |
| Enterprise Value | 11.42B |
Important Dates
The next confirmed earnings date is Tuesday, February 24, 2026, after market close.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 133.84 million shares outstanding. The number of shares has increased by 1.31% in one year.
| Current Share Class | 111.41M |
| Shares Outstanding | 133.84M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | -0.81% |
| Owned by Insiders (%) | 17.23% |
| Owned by Institutions (%) | 87.83% |
| Float | 110.49M |
Valuation Ratios
The trailing PE ratio is 28.40 and the forward PE ratio is 20.86. Globus Medical's PEG ratio is 1.32.
| PE Ratio | 28.40 |
| Forward PE | 20.86 |
| PS Ratio | 4.29 |
| Forward PS | 3.69 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 5.34 |
| P/FCF Ratio | 20.19 |
| P/OCF Ratio | 16.37 |
| PEG Ratio | 1.32 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.28, with an EV/FCF ratio of 19.70.
| EV / Earnings | 26.94 |
| EV / Sales | 4.12 |
| EV / EBITDA | 14.28 |
| EV / EBIT | 21.79 |
| EV / FCF | 19.70 |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.13 |
| Quick Ratio | 2.31 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.01% and return on invested capital (ROIC) is 11.60%.
| Return on Equity (ROE) | 10.01% |
| Return on Assets (ROA) | 6.43% |
| Return on Invested Capital (ROIC) | 11.60% |
| Return on Capital Employed (ROCE) | 11.32% |
| Weighted Average Cost of Capital (WACC) | 9.99% |
| Revenue Per Employee | $522,605 |
| Profits Per Employee | $79,958 |
| Employee Count | 5,300 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, Globus Medical has paid $36.72 million in taxes.
| Income Tax | 36.72M |
| Effective Tax Rate | 7.97% |
Stock Price Statistics
The stock price has decreased by -5.68% in the last 52 weeks. The beta is 1.06, so Globus Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -5.68% |
| 50-Day Moving Average | 89.76 |
| 200-Day Moving Average | 68.53 |
| Relative Strength Index (RSI) | 40.59 |
| Average Volume (20 Days) | 1,436,880 |
Short Selling Information
The latest short interest is 3.88 million, so 2.90% of the outstanding shares have been sold short.
| Short Interest | 3.88M |
| Short Previous Month | 4.10M |
| Short % of Shares Out | 2.90% |
| Short % of Float | 3.51% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.77 billion and earned $423.78 million in profits. Earnings per share was $3.08.
| Revenue | 2.77B |
| Gross Profit | 1.87B |
| Operating Income | 523.93M |
| Pretax Income | 460.50M |
| Net Income | 423.78M |
| EBITDA | 799.64M |
| EBIT | 523.93M |
| Earnings Per Share (EPS) | $3.08 |
Balance Sheet
The company has $390.52 million in cash and $120.11 million in debt, with a net cash position of $287.09 million or $2.15 per share.
| Cash & Cash Equivalents | 390.52M |
| Total Debt | 120.11M |
| Net Cash | 287.09M |
| Net Cash Per Share | $2.15 |
| Equity (Book Value) | 4.40B |
| Book Value Per Share | 32.68 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was $715.20 million and capital expenditures -$135.59 million, giving a free cash flow of $579.61 million.
| Operating Cash Flow | 715.20M |
| Capital Expenditures | -135.59M |
| Free Cash Flow | 579.61M |
| FCF Per Share | $4.33 |
Margins
Gross margin is 67.51%, with operating and profit margins of 18.92% and 15.30%.
| Gross Margin | 67.51% |
| Operating Margin | 18.92% |
| Pretax Margin | 16.63% |
| Profit Margin | 15.30% |
| EBITDA Margin | 28.87% |
| EBIT Margin | 18.92% |
| FCF Margin | 20.93% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.31% |
| Shareholder Yield | -1.31% |
| Earnings Yield | 3.62% |
| FCF Yield | 4.95% |
Analyst Forecast
The average price target for Globus Medical is $97.15, which is 11.09% higher than the current price. The consensus rating is "Buy".
| Price Target | $97.15 |
| Price Target Difference | 11.09% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 8.54% |
| EPS Growth Forecast (5Y) | 59.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 9.87 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.87 |
| Piotroski F-Score | 7 |